• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Parkinson’s disease monitoring is in Great Lakes NeuroTech’s spotlight

Parkinson’s disease monitoring is in Great Lakes NeuroTech’s spotlight

August 3, 2011 By MedCity News

A Cleveland startup is looking for strategic partners for its web-based systems that assesses the severity of Parkinson’s disease symptoms and helps doctors better tailor medications to people with Parkinson’s.

Great Lakes NeuroTechnologies has been around since 2006 as a division of Cleveland Medical Devices, but was spun off earlier this year as a stand-alone company to focus on movement disorders.

One key product, the Kinesia HomeView, is a take-home kit that guides people with Parkinson’s disease through a series of motor tests designed to help doctors see how patients respond to the medications they’ve been using.

MedCity News logo

Parkinson’s is a nervous system disorder that affects patients’ ability to move. There is no cure.

The kit includes a motion sensor worn on a patient’s finger to capture data on a prescribed series of movements, such as touching the nose and tapping the fingers. The tests provide a quantitative measurement of two major Parkinson’s symptoms: tremors and bradykinesia, a condition marked by slowness of movement.

“These symptoms can change a lot during the course of a day based on the therapies a patient is receiving,” company presdient Joe Giuffrida said.

The at-home test kit has obvious value for Parkinson’s patients, who can be monitored by their doctors around the clock while providing updates on their symptoms through data transmitted over the Internet. For health professionals, the big advantage is the objective measurement of symptoms that the tool provides. In general, clinicians currently monitor Parkinson’s symptoms through subjective, mostly visual evaluations of symptoms in the clinic, according to Giuffrida.

Great Lakes has received the necessary regulatory approvals to sell the HomeView device in the U.S. and Europe, so the key for the company now is to reach distribution and partnership agreements that’ll help it market the product to a wider base of end users, Giuffrida said. The company sells the device to neurologists, researchers and pharmaceutical companies conducting clinical trials.

One thing the 16-employee company doesn’t need is investment funding. It’s raised about $10 million over its lifetime in grants, mainly from the National Institutes of Health, and is generating revenue through sales Giuffrida said.

Filed Under: Diagnostics, News Well Tagged With: Cleveland Clinic, Great Lakes NeuroTechnologies, Parkinson's disease

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy